Table 5.
association of patients' socioeconomic and clinical characteristics with a change in HbA1c (N=40)
| Variables | HbAlc (mean ± SD) | Test value | P-value |
|---|---|---|---|
| Gender | |||
| Male | -0.76 ± 0.48 | 41 | 0.295a |
| Female | -0.43 ± 0.36 | ||
| Socioeconomic level | |||
| Very low/ low | -0.37 ± 0.33 | 7.2 | 0.027*b |
| Middle | -0.68 ± 0.29 | ||
| High | -1.25 ± 0.35 | ||
| Duration of DM, n (%) | |||
| < 5 years | -0.752 ± 0.32 | 1.16 | 0.446 |
| 5-10 years | -0.46 ± 0.50 | ||
| > 10 years | -0.44 ± 0.34 | ||
| Comorbidities, n (%) | |||
| Absent | -0.65 ± 0.42 | 59 | 0.153a |
| Present | -0.41 ± 0.37 | ||
| Morsiky Medication Adherence Scale level | |||
| Low | -0.30 ± 0.28 | 0.94 | 0.624 |
| Medium | -0.40 ± 0.42 | ||
| High | -0.56 ± 0.39 |
P-values are based on the Mann-Whitney U test. Statistical significance at P < 0.05. b p-values are based on the Kruskal-Wallis test. Statistical significance at P < 0.05.